REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 155 filers reported holding REVANCE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.49 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $357,000 | -5.8% | 12,818 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $379,000 | +5.9% | 12,818 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $358,000 | +11.9% | 12,818 | +13.4% | 0.00% | +100.0% |
Q4 2020 | $320,000 | +12.7% | 11,306 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $284,000 | +2.9% | 11,306 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $276,000 | +65.3% | 11,306 | +0.4% | 0.00% | 0.0% |
Q1 2020 | $167,000 | -25.4% | 11,257 | -18.4% | 0.00% | 0.0% |
Q4 2019 | $224,000 | +25.1% | 13,794 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $179,000 | +17.0% | 13,794 | +16.6% | 0.00% | 0.0% |
Q2 2019 | $153,000 | – | 11,834 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NovaQuest Capital Management, L.L.C. | 1,558,426 | $48,000,000 | 65.50% |
Essex Woodlands Management, Inc. | 3,842,047 | $118,335,000 | 25.90% |
Rhenman & Partners Asset Management AB | 203,181 | $6,258,000 | 0.77% |
EAM Global Investors LLC | 44,898 | $1,383,000 | 0.72% |
Fosun International Ltd | 319,313 | $9,835,000 | 0.62% |
EAM Investors, LLC | 113,096 | $3,483,000 | 0.58% |
ArrowMark Colorado Holdings LLC | 1,735,699 | $53,460,000 | 0.53% |
Perceptive Advisors | 618,957 | $19,064,000 | 0.53% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 111,360 | $3,430,000 | 0.45% |
Schonfeld Strategic Advisors LLC | 83,700 | $2,578,000 | 0.19% |